Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma

Journal of Clinical Immunology

Volumn 21, Issue 3, 2001, Pages 175-182

  Broide, David H ^a,b   Stachnick, Greg ^a   Castaneda, Diego ^a   Nayar, Jyothi ^a   Miller, Marina ^a   Cho, Jae Youn ^a   Roman, Mark ^a   Zubeldia, Jose ^a   Hyashi, Tomoko ^a   Raz, Eyal ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; CpG motif; Eosinophils; IL 5; Interferon

Indexed keywords

IMMUNOSTIMULATING AGENT; IMMUNOSTIMULATORY DNA SEQUENCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; DOSE RESPONSE; DRUG MECHANISM; EOSINOPHIL; FEMALE; GENE THERAPY; IMMUNOSTIMULATION; INHALATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ASTHMA; BASE SEQUENCE; BRONCHIAL HYPERREACTIVITY; CPG ISLANDS; CYTOKINES; DISEASE MODELS, ANIMAL; DNA; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C; OVALBUMIN; TH1 CELLS; TH2 CELLS;

EID: 0035038915     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011078930363     Document Type: Article

References (20)

1. 1. Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, Van Uden J, Martin-Orozco E, Gelfand EW, Raz E: Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 161: 7054-7062, 1998
2. 2. Broide D, Raz E: DNA-Based immunization for asthma, Int Arch Allergy Immmol 118:453-456, 1999
3. 3. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160:2555-2559, 1998
4. 4. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM: Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 162:6284-6293, 1999
5. 5. Castro M, Chaplin DD, Walter MJ, Holtzman MJ: Could asthma be worsened by stimulating the T-helper type I immune response? Am J Resp Cell Mol Biol 22:143-146, 2000
6. 6. Von Hertzen LC, Haahtela T: Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type I response? Am J Resp Cell Mol Biol 22:139-142, 2000
7. 7. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, Raz E: Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 106:124-134, 2000
8. 8. Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, Swain SL, Spiegelberg HL, Carson DA: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization, Proc Natl Acad Sci USA 93: 5141-5145, 1996
9. 9. Kobayashi H, Horner AA, Takabayashi K, Nguyen M-D, Huang E, Cinman N, Raz E: Immunostimulatory DNA prepriming: A novel approach for prolonged Th1 biased immunity. Cell Immunol 198:69-75, 1999
10. 10. Spiegelberg HL, Tighe H, Roman M, Broide D, Raz E: Inhibition of IgE formation and allergic inflammation by allergen gene immunization and by CpG motif immunostimulatory oligodeoxynucleotides. Allergy 53:93-97, 1998
11. 11. Kohama Y, Akizuki O, Hagihara K, Yamada E, Yamamoto H: Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice: J Allergy Clin Immunol 104:1231-1238, 1999
12. 12. Jahn-Schmid B, Wiedermann U, Bohle B, Repa A, Kraft D, Ebner C: Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. J Allergy Clin Immunol 104:1015-1023, 1999
13. 13. Shirota H, Sano K, Kikuchi T. Tamura G, Shirato K: Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 164:5575-5582, 2000
14. 14. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186:1623-1631, 1997
15. 15. Hartmann G, Weiner GJ, Krieg AM: CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 96:9305-9310, 1999
16. 16. Kranzer K. Bauer M, Lipford GB, Heeg K, Wagner H, Lang R: CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Immunology 99:170-178, 2000
17. 17. Magone TM, Chan C-C, Beck L, Whitcup SM, and Raz E: Systemic and mucosal administration of ISS inhibits early and late phases of immune allergic conjunctivitis. Eur J Immunol 30:1841-1850, 2000
18. 18. Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 103:175-183, 1999
19. 19. Randolph DA, Stephens R, Carruthers CJ, Chaplin DD: Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 104:1021-1029, 1999
20. 20. Kline JN, Krieg AM, Waldschmidt TJ, Ballas ZK, Jain V, Businga TR: CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 104:1258-1264, 1999